Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze NKTR stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate NKTR investment potential.

What is NKTR stock price today?

Get real-time NKTR stock price, historical data, and price charts on Financhill. Track NKTR performance with our advanced analysis tools.

Is NKTR a good investment?

Evaluate NKTR investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy NKTR stock?

To buy NKTR stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of NKTR?

View detailed market capitalization data and company valuation metrics for NKTR on our comprehensive analysis page.

What is the P/E ratio of NKTR?

Use our fundamental analysis tools to view NKTR P/E ratio and compare valuation metrics with industry peers.

What are NKTR earnings?

View NKTR earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Nektar Therapeutics 10K Form

Sell

NKTR
Nektar Therapeutics

Last Price:

$57.53

Seasonality Move:

15.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10	10Q	NKTR/Nektar Therapeutics Quarterly
2023-11-08	10Q	NKTR/Nektar Therapeutics Quarterly
2023-08-09	10Q	NKTR/Nektar Therapeutics Quarterly
2023-05-10	10Q	NKTR/Nektar Therapeutics Quarterly
2022-11-04	10Q	NKTR/Nektar Therapeutics Quarterly
2022-08-05	10Q	NKTR/Nektar Therapeutics Quarterly

Receive NKTR News And Ratings

See the #1 stock for the next 7 days that we like better than NKTR

NKTR Financial Statistics

Sales & Book Value

Annual Sales:	$98.4M
Cash Flow:	$-48.9M
Price / Cash Flow:	0
Annual Sales:	$4.33
Price / Book:	11.73

Profitability

EPS (TTM):	-4.55860
Net Income (TTM):	$-120.7M
Gross Margin:	$66.5M
Return on Equity:	-327.67%
Return on Assets:	-43.84%

Nektar Therapeutics Earnings Forecast

Key Nektar Therapeutics Financial Ratios

The Gross Profit Margin over the past 31 years for NKTR is 67.54%.
The Selling, General & Administrative Expenses for NKTR have been equal to 77.98% of Gross Profit Margin.
The Research & Development expenses have been 121.55% of Revenue.
The Net Earning history of NKTR is -120.86% of Total Revenues.
Per Share Earnings over the last 31 years have been positive in 16 years.

Nektar Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Pharmaceuticals
Sector:	Health Care
Current Symbol:	NKTR
CUSIP:	640268
Website:	nektar.com

Debt

Debt-to-Equity Ratio:	1.96
Current Ratio:	4.24
Quick Ratio:	4.07

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

NKTR Technical Analysis vs Fundamental Analysis